PRECISEDX
PreciseDx is the only Cancer Risk Stratification company to provide patient-specific risk information through the analysis of morphology features, enabling better and more personalized treatment and outcomes. Clinical teams can rely on PreciseDx for unmatched insights and actionable intelligence in determining the best treatment for each patient. Combining the power of artificial intelligence with its proprietary Morphology Feature Array™, PreciseDx creates disease-specific assays that deliver new levels of pathology information and insight on each patient's risk profile and likely outcomes to aid in treatment decision-making.
PRECISEDX
Industry:
Health Care
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.precisedx.ai
Status:
Active
Contact:
646-818-9330
Email Addresses:
[email protected]
Total Funding:
10.75 M USD
Investors List
IBM Ventures
IBM Ventures investment in Series A - PreciseDx
Merck Global Health Innovation Fund
Merck Global Health Innovation Fund investment in Series A - PreciseDx
Mount Sinai Health System
Mount Sinai Health System investment in Series A - PreciseDx
Agilent Technologies
Agilent Technologies investment in Series A - PreciseDx
Official Site Inspections
http://www.precisedx.ai
- Host name: 196.68.238.104.host.secureserver.net
- IP address: 104.238.68.196
- Location: Scottsdale United States
- Latitude: 33.6013
- Longitude: -111.8867
- Metro Code: 753
- Timezone: America/Phoenix
- Postal: 85260
